Tag: Human Papillomavirus (HPV)
Age to Stop Cervical Cancer Screening Depends on Test Used
Negative HPV test, HPV-cytology co-test tied to low remaining lifetime cancer risk for unvaccinated
Fewer Parents Have Sexuality, Gender Concerns About HPV Shot
Many parents cite lack of necessity, safety concerns as reasons not to have their adolescents vaccinated
Hispanics With HIV Face Higher Risk for HPV-Related Cancer
But five-year survival was above 50 percent among HIV-infected Hispanics across HPV-related cancer types
HPV Vaccination Not Tied to Risky Sexual Behavior in Teen Girls
Finding among adolescent girls before, after school-based vaccination program
Positive HPV Status Tied to Better Cervical Cancer Prognosis
Five-year relative survival ratio better for hrHPV-positive cases than for hrHPV-negative cases
FDA Approves HPV Vaccine for People Through Age 45
Updated vaccine designed to prevent cancers and disease caused by nine HPV types
More Than 14 Million Preteens Need to Receive HPV Vaccine
>14 million need to receive two doses of vaccine to reach goal of 80 percent vaccination by 2026
Second HPV-Related Primary Cancers Common in Survivors
Persistent HPV infection may be associated with second HPV-related primary cancers
Total of 43,371 New Cases of HPV-Associated Cancers in 2015
Decreases in cervical cancer, vaginal SCC from 1999 to 2015; increases in oropharyngeal, anal, vulvar SCC
Oral High-Risk HPV Prevalence Appears to Be Low in England
Smoking and sexual behavior associated with high-risk HPV status